Stock LGC CAPITAL LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

LGC Capital Ltd Stock Toronto S.E.

Equities

CA50189Q1000

Investment Management & Fund Operators

Financials

Sales 2021 - Sales 2022 - Capitalization 13.04M 17.8M
Net income 2021 -3M -4.1M Net income 2022 -14M -19.11M EV / Sales 2021 -
Net cash position 2021 7.04M 9.61M Net Debt 2022 5.55M 7.58M EV / Sales 2022 -
P/E ratio 2021
-4.56 x
P/E ratio 2022
-0.91 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 100%
More Fundamentals * Assessed data

Chart LGC Capital Ltd

Dynamic Chart

Latest news about LGC Capital Ltd

Elixxer Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Elixxer Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Elixxer Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Elixxer Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Elixxer Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021. CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021. CI
Elixxer Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Elixxer Ltd.'s Equity Buyback announced on July 6, 2021, has expired with 430,731 shares, representing 3.90% for CAD 0.58 million. CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021. CI
Elixxer Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Elixxer Ltd. Auditor Raises 'Going Concern' Doubt CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021. CI
Elixxer Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Elixxer Up 7.5% after Reporting Binding Offer to Sell Viridi Stake for $1 Million MT
More news

Press releases LGC Capital Ltd

IIROC Trading Halt - ELXR AQ
Elixxer : Management Discussion and Analysis PU
Elixxer : Announces Intention to Consolidate its Common Shares AQ
Elixxer : Closing Securities-for-Debt transactions positions Elixxer to profit from medical cannabis in the EU and elsewhere AQ
Elixxer : Investment in Australian Company Makes 120% Gain through Recent Acquisition AQ
More press releases

Managers and Directors - LGC Capital Ltd

Managers TitleAgeSince
Ferras Zalt CEO
 Chief Executive Officer 61 19-04-30
Kym No DFI
 Director of Finance/CFO 58 -
Rafi Hazan BRD
 Director/Board Member - 05-12-31
Members of the board TitleAgeSince
Guy Charette LAW
 General Counsel 70 13-05-31
Rafi Hazan BRD
 Director/Board Member - 05-12-31
Ferras Zalt CEO
 Chief Executive Officer 61 19-04-30
More insiders

Company Profile

Elixxer Ltd. is a Canada-based investment company. The Company has investments and activities in the legal cannabis sector. The Company is focused on investing opportunities in various sectors, with a priority on growth companies that are past the start-up phase.
Sector
Investment Management & Fund Operators
Calendar
2024-04-28 - Q4 2023 Earnings Release (Projected)
More about the company

Sector Other Investment Management & Fund Operators

1st Jan change Capi.
BLACKROCK, INC. Stock BlackRock, Inc.
-6.35% 113B
APOLLO GLOBAL MANAGEMENT, INC. Stock Apollo Global Management, Inc.
+20.42% 63.85B
BROOKFIELD CORPORATION Stock Brookfield Corporation
+5.42% 61.9B
BANK OF NEW YORK MELLON CORPORATION (THE) Stock Bank of New York Mellon Corporation (The)
+10.30% 42.86B
AMERIPRISE FINANCIAL, INC. Stock Ameriprise Financial, Inc.
+9.51% 40.84B
3I GROUP PLC Stock 3i Group plc
+18.75% 34.58B
T. ROWE PRICE GROUP INC. Stock T. Rowe Price Group Inc.
+4.93% 25.46B
STATE STREET CORPORATION Stock State Street Corporation
-4.14% 22.13B
PRINCIPAL FINANCIAL GROUP, INC. Stock Principal Financial Group, Inc.
+1.97% 18.61B
Other Investment Management & Fund Operators
  1. Stock Market
  2. Equities
  3. ELXR Stock
  4. Stock